Recent studies demonstrated that freshwater clam (Corbicula fluminea) has lipid-lowering and hepatoprotective activities, but its effect on immune responses has not yet been addressed. Here we showed that ethanol extracts of C. fluminea (ECF) reduced nitrite oxide, interleukin-1, interleukin-6, and tumor necrosis factor- in lipopolysaccharide-activated macrophages. Further, ECF was fractionated into n-hexane, ethyl acetate, ethanol, and water soluble fractions. Of these, the ethyl acetate soluble fraction (EACF) had the highest capacity to inhibit pro-inflammatory mediators expression. The underlying mechanisms for the anti-inflammatory activity of EACF were demonstrated as down-regulation of ERK1/2, JNK1/2, and p38 phosphorylation and NF-B activity. Using gas chromatography-mass spectrometric analysis EACF was found to be composed mainly of fatty acids and steroids. Our results provide evidence that freshwater clam has anti-inflammatory activity, and support the possibility for the development of freshwater clam as a health supplement or adjuvant therapeutic agent for either preventing or treating inflammation related diseases.
The freshwater clam, a popular edible shellfish in Asia, is traditionally used to improve health. Chijimatsu et al. showed that water extracts of freshwater clam reduced cholesterol level and hepatic lipids in normal rats and hypercholesterolemic rats fed chloretone by increasing cholesterol 7R-hydroxylase and reducing apolipoprotein A-I gene expression in liver [1] . The authors further demonstrated that the fat and protein fractions of the water extracts showed hypocholesterolemic effects by enhancing excretion of neutral sterols and increasing biosynthesis of bile acids in hypercholesterolemic rats fed a high-cholesterol diet [2] . The hypolipidemic and hypocholesterolemic effects of water extracts of freshwater clam were also demonstrated using a tilapia fish model, evidenced by reducing total triacylglycerol, cholesterol, and low density lipoproteins in plasma, while increasing plasma total antioxidant capacity [3] . Oral administration of water extracts of freshwater clam reduced the serum levels of alanine aminotransferase and aspartate aminotransferase as well as reducing liver fibrosis in rats treated with carbon tetrachloride [4] . The hepatoprotective effects of the extracts were confirmed in an acute liver injury model in rat with hemorrhagic shock [5, 6] . In addition to the water extract, the methanol extract induced HL-60 apoptosis, mainly associated with reactive oxygen species production, glutathione depletion, mitochondrial dysfunction, and caspase activation [7] . The benefits of freshwater clam might be through modulating inflammatory responses [5, 6] ; to date, however, the effect of freshwater clam on immune modulation has not been investigated.
The inflammatory responses of mammals are triggered by pathogen associated molecular patterns that are shared by groups of different microbial pathogens, which are recognized by toll-like receptors (TLR) expressed on the cell surface of immune cells [8] . Lipopolysaccharide (LPS), one of the most important pathogen associated molecular patterns, activates macrophages by binding to TLR4 [9] . Binding of LPS to TLR4 triggers the down-stream signaling cascades, including mitogen-activated protein kinases (MAPKs) [10] and nuclear transcription factor kappa-B (NF-B) pathways [11] , which lead to the production of inflammatory mediators from macrophages, such as tumor necrosis factor-alpha (TNF-), interleukin-1 (IL-1), interleukin-6 (IL-6), and nitric oxide (NO) [12] . Inflammatory responses for a short and controlled duration can be beneficial because they help against the infection; however, prolonged and acute inflammation characterized by excessive production of inflammatory mediators can be harmful because it may cause host toxicity and tissue damage [13] . Inflammation plays an important role in disease pathogenesis, including type II diabetes [14] , atherosclerosis [15] , gout [16] , and chronic renal disease [17] .
Development of a potential therapeutic approach to modulate inflammatory disease has become ever more popular and, seemingly, important. Foods are important sources for development of anti-inflammatory agents because they are expected to be safe and are not perceived as medicine. Our current studies showed that food and herb medicines have one or more substances with anti-inflammatory functions by reducing pro-inflammatory mediator production in LPS-activated cells [18] [19] [20] [21] . In this study, we demonstrated the anti-inflammatory activity of freshwater clams; the results provide support for the potential as either a health supplement or future pharmaceutical application of freshwater clams for immune modulation purposes. supplement or future pharmaceutical application of freshwater clams for immune modulation purposes.
Ethanol extracts of Corbicula fluminea reduce NO, IL-1, IL-6, and TNF- expression in LPS-activated macrophages:
Ethanol extracts of Corbicula fluminea (ECF), but not water extracts (WCF), reduced NO generation in a dose-dependent manner ( Figure 1A ). ECF also reduced the expression levels of IL-6 ( Figure 1B ) and TNF- ( Figure 1C ), as well as IL-1 secretion, IL-1 precursor (proIL-1) protein expression, and IL-1 mRNA expression ( Fig. 1D , top, middle, and bottom panels, respectively). The cell viability was not reduced significantly when macrophages were treated with ≤ 1000 μg/mL ECF ( Figure 1E ). This result indicated that ECF-mediated reduction of NO generation and cytokine expression was not due to reduction of cell viability.
Fractionation of ethanol extract of Corbicula fluminea and its anti-inflammatory activity:
The ECF was fractioned into n-hexane, ethyl acetate, methanol, and water soluble fractions, and these were evaluated for their anti-inflammatory activity. The n-hexane, ethyl acetate, and ethanol fractions significantly inhibited NO generation in LPS-activated macrophages in a dose-dependent manner, and the ethyl acetate fraction showed the best activity ( Figure 2A ). Since the ethyl acetate fraction of ECF (EACF) significantly reduced NO generation in LPS-activated macrophages, we investigated its effect on the protein expression of inducible NO synthase (iNOS), the enzyme that catalyzes NO generation. EACF reduced iNOS expression in a dose-dependent manner ( Figure 2B ); however, it did not reduce cyclooxygenase-2 (COX-2) expression in LPSactivated macrophages ( Figure 2C ). We also demonstrated that the secretion of IL-6 ( Figure 2D ) and TNF- ( Figure 2E ) were reduced by EACF in a dose-dependent manner. These results indicated that EACF was the major ingredient of ECF with anti-inflammatory activity.
Effect of EACF on MAPK phosphorylation in LPS-activated macrophages:
LPS potently induced macrophages to produce the pro-inflammatory cytokines by activation of TLR4 through many signaling pathways, including ERK1/2, JNK1/2, and p38 [20, 21] . EACF reduced phosphorylation levels of ERK1/2 ( Figure 3A 
Effect of EACF on NF-B activation in LPS-activated macrophages:
NF-B, one of the important transcription factors, regulates inflammatory related genes expression in LPS-activated macrophages [20, 21] . In resting macrophages, NF-κB is sequestered in the cytoplasm as an inactive precursor complex by its inhibitory protein, IκB. Upon LPS stimulation, IκB is phosphorylated by IκB kinase, ubiquitinated, and rapidly degraded via proteasomes to release NF-κB [22] . We found that the phosphorylation level of IκB-was reduced by EACF ( Figure 4A ). Using NF-B-dependent alkaline phosphatase reporter cells, we demonstrated that NF-B transcriptional activity in LPS-stimulated macrophages was reduced by EACF ( Figure 4B ) and by N-acetylcysteine (NAC), an anti-oxidant used as a positive control [21] . These results indicated that EACF could inhibit the activation of the NF-B signaling cascades in LPS-activated macrophages. Table 1 shows the composition of EACF; 29 compounds were identified by GC-MS. EACF contained fatty acids and fatty acid derivatives (27.9%), steroids (43.5%), and amides (24.6%). The 10 major constituents were cholesterol (22.7%), n-hexadecanoic acid (9.8%), 3-benzyl-6isobutyl-2,5-piperazinedione (6.5%), cis-9-octadecenoic acid (5.8%), campesterol (5.5%), 3,6-diisobutyl-2,5-piperazinedione (4.8%), crinosterol (4.0%), Z-11-hexadecenoic acid (3.4%), stigmasterol (3.2%), and dl-alanyl-l-leucine (3.1%).
Chemical composition of EACF:
Inflammation not only participates in host defense, but also controls the pathogenesis of many diseases including type 2 diabetes mellitus [14, [23] [24] [25] , atherosclerosis [15, 26] , obesity [14, 26] , silicosis [27] , Alzheimer's disease [28] , gout [16, 24] , and kidney disease [17, 18] . Elevated circulating inflammatory cytokines, in particular, a combined elevation of IL-1 and IL-6, is a risk factor for the pathogenesis of type II diabetes mellitus [29] . Blockade of IL-1 signaling by the IL-1 receptor antagonist or IL-1 deficiency protected cultured human islets from high-glucose induced apoptosis and impaired function [30] . These results indicated that IL-1 and IL-6 play an important role in the pathogenesis of type II diabetes mellitus. Type II diabetes mellitus is a leading cause of end-stage kidney disease in the world due to diabetic nephropathy, which features progressive renal fibrosis/sclerosis and inflammation as the major pathogenic pathway [31] . We showed that methanol extracts of C. fluminea inhibited IL-1 and IL-6 expression, showing that it might have the potential to be a health supplement for prevention of diabetes and diabetic nephropathy.
Atherosclerosis is also the hallmark of inflammatory disease triggered by endogenous danger signals, including cholesterol [15, 32] . Cholesterol crystals induce IL-1 secretion through NLRP3 inflammasome in LPS-primed mice and human macrophages [15] . Human carotid plaque lipid extract and oxidized low density lipoproteins promote inflammation by increasing the expression of IL-1β, IL-6, and TNF-α in monocytes [33, 34] . Knockout of inflammatory genes that have been implicated in atherogenesis leads to reduced atherosclerosis [35] . The wellstudied function of freshwater clam is its lipid-lowering property. Water extracts reduced total triacylglycerol, cholesterol, and low density lipoproteins, suggesting that freshwater clam might be of benefit to atherosclerosis prevention [1] [2] [3] . Our findings provide novel evidence that freshwater clam reduces the inflammatory response and exerts its anti-atherogenic actions against inflammation beyond its lipid-lowing effect.
Stigmasterol (3.2% in EACF) significantly inhibited the transcriptional activity of NF-B in LPS/IFN-gamma stimulated macrophages [36] . Campesterol (5.5% in EACF) inhibits prostaglandin E 2 and prostaglandin I 2 release from LPS-activated macrophages, maybe by alteration of the enzymatic activities of COX-2 and phospholipases A2, which may lead to a slow down of the atheroma development [37] . However, campesterol slightly increased the secretions of IL-6 and TNF- from LPS-activated mouse peritoneal macrophages, but the extent of these increases was less pronounced than that of cholesterol [38] . Oleic acid (cis-9octadecenoic acid, 5.8% in EACF) reduces the expression of iNOS and COX-2, as well as the production of NO and prostaglandin E2, by inhibiting reactive oxygen species (ROS), p38 MAPK, and Akt/IKK/NF-B signaling pathways in LPS-stimulated BV2 microglia [39] . The ethyl acetate fraction also contains saturated 1438 Natural Product Communications Vol. 7 (11) 2012 Hua et al.
fatty acids and cholesterol (22.7% in EACF) that might induce inflammation and atherosclerosis. The saturated fatty acids palmitic acid (n-hexadecanoic acid, 9.8% in EACF) and stearic acid (noctadecanoic acid, 1.8% in EACF) induced expression of TNF-, IL-8 and IL-1, and enhanced LPS-induced IL-1 secretion in phorbol ester-differentiated human THP-1 macrophages, suggesting that these saturated fatty acids might contribute to the activation of macrophages in atherosclerotic plaques [40] . Palmitic acid has been demonstrated to induce IL-1β and IL-18 production through NLRP3 inflammasome and impaired insulin signaling [25] . Removal of the cholesterol and the saturated fatty acids might improve the anti-inflammatory activity of freshwater clam.
In conclusion, in the present study we demonstrated the antiinflammatory activity of extracts of freshwater clam in macrophages and analyzed their chemical composition. The antiinflammatory activity might result from inhibition of the activation of MAPKs and NF-B. These results provide possible mechanisms for the prevention or improved inflammation associated disorders produced by freshwater clam.
Experimental

Materials:
Freshwater clam (Corbicula fluminea) powder was provided by LiChuan Aquaculture Farm (Hualien, Taiwan). LPS (from Escherichia coli 0111:B4), mouse antibodies against mouse phospho-ERK1/2, phospho-JNK1/2, phospho-p38, and actin were purchased from Sigma (St. Louis, MO). Rabbit antibodies against mouse ERK1/2, JNK1, p38, phospho-IB-, iNOS, COX-2, and HRP-second antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). IL-1, IL-6, and TNF- ELISA kits were purchased from R&D Systems (Minneapolis, MN).
Extraction and fractionation of Corbicula fluminea:
The powder of the edible portion of C. fluminea (50 g, dry weight) was extracted with either 500 mL ethanol for 16 h or with 500 mL boiling water for 2 h. The extracts were concentrated and dried to give ethanol (ECF) and water extracts (WCF), respectively. ECF (20 g) was successively liquid-liquid partitioned with n-hexane, ethyl acetate, ethanol, and water (each solvent volume 300 mL, repeated 3 times). The collected soluble fractions were dried to give n-hexane, ethyl acetate, ethanol, and water soluble fractions, respectively.
Gas chromatography-mass spectrometry (GC-MS) analysis:
The ethyl acetate fraction was analyzed by GC-MS (HP 6890N, with MS detector model HP 5973) using a DB-5HT column, 15 m in length, 0.25 mm i.d., and 0.1 m film. The oven temperature was increased from 85 to 275°C at a rate of 10°C min-1. The injection temperature was 300°C, and the detector temperature 280°C; helium was used as the carrier gas at a split ratio of 20:1. The compounds were identified by comparison of their mass spectrometric fragmentation patterns with those of authentic standards.
Cell culture: RAW 264.7 macrophages were obtained from the American Type Culture Collection (Rockville, MD). RAW-Blue™ cells, RAW 264.7 macrophages, which stably express a secreted embryonic alkaline phosphatase (SEAP) gene inducible by NF-κB, are resistant to the selectable marker Zeocin™ (InvivoGen, San Diego, CA, USA). The cells were propagated in RPMI-1640 medium (Gibco Laboratories, Grand Island, NY) supplemented with 10% heat-inactivated fetal calf serum (Biological Industries Ltd, Kibbutz Beit Haemek, Israel), and 2 mM L-glutamine (Life Technologies, Carlsbad, CA) at 37C in a 5% CO 2 incubator.
Enzyme-linked immunosorbent assay (ELISA):
Cells (2 × 10 6 in 2 mL medium) were seeded in 60 mm dishes and treated as indicated. In brief, 50 µL of biotinylated antibody and 50 µL of supernatant were added to a stripwell plate precoated with antimouse IL-1, IL-6, and TNF- antibodies and incubated at room temperature for 2 h. After 3 washes with washing buffer, 100 µL of diluted HRP-conjugated streptavidin concentrate was added to each well and the plate incubated at room temperature for 30 min. The washing process was repeated, then 100 µL of a premixed tetramethylbenzidine substrate solution was added to each well and the reaction developed at room temperature in the dark for 30 min. Following addition of 100 µL of stop solution to each well, the absorbance was read in a microplate reader at 450 nm.
NO inhibitory assay:
Cells were seeded in a 24-well plate at a density of 2 × 10 5 cells in 0.5 mL medium, and then incubated with or without LPS (1 µg/mL) in the absence or presence of tested sample for 24 h. Effects of tested sample on NO generation were measured indirectly by analysis of nitrite levels using the Greiss reaction.
NF-B reporter assay:
RAW-Blue™ cells were seeded in 60 mm dishes at a density of 1 × 10 6 in 2 mL medium and grown overnight in a 5% CO 2 incubator at 37°C. After pre-treatment with tested sample, followed by LPS stimulation for 24 h, the medium was harvested. Medium samples (20 μL) were then mixed with QUANTI-Blue™ (InvivoGen) medium (200 μL) in 96-well plates at 37°C for 15 min. The results of SEAP activity were assessed by reading OD at 655 nm using an ELISA reader.
Western blot assay:
After treatment, the cells were collected and lysed at 4°C in lysis buffer (25 mM Tris-HCl, pH 7.5, 100 mM NaCl, 2.5 mM EDTA, 2.5 mM EGTA, 20 mM NaF, 1 mM Na 3 VO 4 , 20 mM sodium β-glycerophosphate, 10 mM sodium pyrophosphate, 0.5% Triton X-100) containing protease inhibitor cocktail (Sigma, St. Louis, MO), then the whole cell lysate was separated by SDS-PAGE and electrotransferred to a PVDF membrane. The membranes were incubated for 1 h at room temperature in blocking solution (5% nonfat milk in phosphate buffered saline with 0.1% Tween 20), then incubated for 2 h at room temperature with specific primary antibody in blocking solution. After 3 washes in PBS with 0.1% Tween 20, the membrane was incubated for 1 h at room temperature with HRPconjugated secondary antibody in blocking buffer and developed using an enhanced chemiluminescence Western blot detection system.
Statistical analysis:
All values are given as means ± S. E. Data analysis involved one-way ANOVA with subsequent Scheffé test. * and ** indicate a significant difference at the level of p < 0.05 and P < 0.01, respectively, compared to LPS alone.
